Thymidylate Synthase in Advanced Gastrointestinal and Breast Cancers

References

• The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Superiority of sequential methotrexate fluorouracil and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial. J Clin Oncol 1989; 7: 1437–46
   PubMed Web of Science ®Google Scholar
• The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Biochemical modulation of 5-fluorouracil: A randomized comparison of sequential methotrexate 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. Ann Oncol 1993; 4: 235–40
   PubMedGoogle Scholar
• Peters G. J., van der Wilt C. L., Van Groeningen C. J., Smid K., Meijer S., Pinedo H. M. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: Implications for treatment with fluorouracil. J Clin Oncol 1994; 12: 2035–42
   PubMed Web of Science ®Google Scholar
• Weber G. Biochemical strategy of cancer cells and the design of chemotherapy: GHA Clowes memorial lecture. Cancer Res 1983; 43: 3466–92
   PubMed Web of Science ®Google Scholar
• Heidelberger C., Danneberg P. B. Fluorinated pyrimidines: A new class of tumor inhibitory compounds. Nature 1957; 179: 663–6
   PubMed Web of Science ®Google Scholar
• Danenberg P. Thymidylate synthase- A target enzyme in cancer chemotherapy. Biochem Biophys Acta 1977; 473: 73–92
   PubMed Web of Science ®Google Scholar
• Spears C. Clinical resistance to antimetabolites. Heamatol Oncol Clin North Am 1995; 9: 397–413
   PubMed Web of Science ®Google Scholar
• Chu E., Koeller D., Johnston P., Zinn S., Allegra C. Regulation of thymidylate synthase in human colon cancer cells treated 5-fluorouracil and interferon-g. Mol Pharmacol 1993; 43: 527–33
   PubMed Web of Science ®Google Scholar
• Swain S. M., Lippmann M. E., Egan E. F., Steinberg S. M., Allegra C. J. Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 1989; 7: 890–9
   PubMed Web of Science ®Google Scholar
• van der Wilt C. L., Pinedo H. M., Smid K., Peters G. J. Elevation of thymidylate synthase following 5-FU treatment is prevented by the addition of leucovorin in murine colon tumors. Cancer Res 1992; 52: 4922–8
   PubMed Web of Science ®Google Scholar
• Spears C. P., Gustavsson B. G., Berne M., Frösing R., Bernstein L., Hayes A. A. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. Cancer Res 1988; 48: 5894–900
   PubMed Web of Science ®Google Scholar
• Johnston P., Fisher E., Rockette H., et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 1994; 12: 2640–7
   PubMed Web of Science ®Google Scholar
• Suzuki M., Ohwada M., Tamada T., Tsuru S. Thymidylate synthase activity as a prognostic factor in ovarian cancer. Oncology 1994; 51: 334–8
   PubMedGoogle Scholar
• Spears C. P., Gustavsson B. G. Methods for thymidylate synthase pharmacodynamics: serial biopsy, free and total TS, FdUMP and dUMP, and H4PteGlu and CH2FH4PteGlu assays. Adv Exp Med Biol 1988; 244: 97–106
   PubMedGoogle Scholar
• Priest D. G., Bunni M., Sirotnak F. M. Relationship of reduced folate changes to inhibition of DNA synthesis induced by methotrexate in L1210 cells in vivo. Cancer Res 1989; 49: 4204–9
   PubMedGoogle Scholar
• Carriaga M. T., Henson D. E. The histologic grading of cancer. Cancer 1995; 75: 406–21
   PubMedGoogle Scholar
• Leichman L., Danenberg P., Leichman C., et al. Intratumoral thymidylate synthase expression and response to 5-fluorouracil (5FU)-leucovorin (LV) in patients with colorectal cancer. Proc Am Assoc Cancer Res 1993
   Google Scholar
• Gustavsson B. G., Carlsson G., Frösing R., Spears C. P. Pharmacodynamics of 5-FU and leucovorin. Adv Exp Biol Med 1988; 244: 219–24
   PubMedGoogle Scholar
• Spears C. P., Carlsson G., Muggia F. M., Waugh W., Jaresko G., Gustavsson B. G. Aspects of one-carbon folate cycling related to fluoropyrimidine and antifolate therapy. Chemotherapy: concepts, mechanisms, and new targets for chemotherapy, F. M. Muggia. Kluwer Academic Publ., Boston, MA 1994
   Google Scholar
• Spears C. P., Gustavsson B. G., Mitchell M. S., et al. Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res 1984; 44: 4144–50
   PubMed Web of Science ®Google Scholar
• Mattern J., Volm M. Detection of resistance proteins in matched primary lung tumors and lymph node metastases. Anticancer Res 1994; 14: 417–20
   PubMedGoogle Scholar
• Spears C. P., Shahinian A. H., Moran R. G., Heidelberger C., Corbett T. H. In vivo kinetics of thymidylate synthetase inhibition in FUra-sensitive and resistant murine colon adenocarcinomas. Cancer Res 1982; 42: 450–6
   PubMed Web of Science ®Google Scholar
• Galivan J., Maley F., Baugh C. Protective effect of pteroyl-polyglutamates and phosphate on the proteolytic inactivation of thymidylate synthetase. Arch Biochem Biophys 1977; 184: 346–54
   PubMedGoogle Scholar
• Spears C. P., Gustavsson B. G., Frösing R. Folinic acid modulation of fluorouracil: tissue kinetics of bolus administration. Invest New Drugs 1989; 7: 27–36
   PubMed Web of Science ®Google Scholar
• Roberts D. An isotopic assay for thymidylate synthetase. Biochemistry 1966; 5: 3546–8
   PubMedGoogle Scholar
• Houghton J. A., Radparvar S., Torrance P. M., Williams L. G., Houghton P. J. Determination of thymidylate synthase activity in colon tumor tissues after treatment with 5-fluorouracil. Biochem Pharmacol 1987; 36: 1285–9
   PubMedGoogle Scholar
• Horikoshi T., Danenberg K. D., Stadlbauer T. H. W., et al. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 1992; 52: 108–16
   PubMed Web of Science ®Google Scholar